DIRS.INFO The most relevant business & tech news

☆ Chart of the Day: Pfizer
▼ + stars: | 2024-10-07 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailChart of the Day: PfizerStarboard takes a $1 billion stake in $PFE. It's our Chart Of The Day. The Investment Committee discuss healthcare and biotech stocks.

Organizations: Pfizer

☆ Cheap stocks to buy in the fourth quarter, according to HSBC
▼ + stars: | 2024-10-05 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

It's officially a new trading month, and HSBC recommends investors broaden their exposure in the fourth quarter by seeking out stocks with more reasonable valuations. "These 'big' companies represent the lion's share of equity index returns year to date." HSBC has a buy rating on the stock. In all, 16 of the 29 analysts covering GM have a strong buy or buy rating, and its average price target of $54.35 implies nearly 19% upside from Friday's close, per LSEG. The remaining 11 have a buy or strong buy rating.

Persons: It's, Nicole Inui, General Motors, Goldman Sachs, Goldman Organizations: HSBC, Dow, Industrial, Nasdaq, Federal Reserve, General, GM, Pharmaceutical, Pfizer, Delta Air Lines Locations: Americas, U.S

☆ Beyond Novo: Fund manager likes this under-the-radar pharma stock with a weight loss drug in the works
▼ + stars: | 2024-10-04 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +3 min

"Maybe that weight loss product (by United Laboratories) works, maybe it doesn't. United Laboratories' price-to-earnings of 5.8 times is a fraction of the 34.3 times that Novo Nordisk is trading at, Peche added. [United Laboratories] is making smooth progress in R & D and targets to launch Liraglutide in 2024. Their comments follow United Laboratories' "faster than expected earnings" growth in the first half of the year. Analysts' average price target on United Laboratories is 12.95 Hong Kong dollars, giving it 28.2% potential upside.

Persons: Sean Peche, it's, Peche, there's, that's, Eli Lilly, Amgen, Carol Dou, Sunny Chen, UOB Kay Hian, bode Organizations: Novo Nordisk, Ranmore Fund Management, United Laboratories, Pfizer, AstraZeneca, Global Equity Fund, Hong, Hong Kong bourse, HK Locations: Hong Kong, Novo, Europe, U.S

☆ OpenAI just secured a ton of new cash. Now it needs to wow us
▼ + stars: | 2024-10-04 | by ( Allison Morrow | ) edition.cnn.com time to read: +6 min

One thing seems clear: The company is burning through far more cash than it’s bringing in, according to reporting from the New York Times. (That’s revenue largely from subscriptions to premium versions of ChatGPT and licensing its tech to third-party developers.) Here’s where things get a little wild:Next year, OpenAI estimates that its revenue will more than triple to $11.6 billion. It’s not clear how, or whether, OpenAI is working on reducing its significant cash burn. “It has nothing to do with reality.”One way OpenAI could improve its margins would be to cut costs.

Persons: CNN Business ’, New York CNN —, Goldman Sachs, that’s, Gil Luria, Davidson, ” Luria, “, Luria, There’s, OpenAI, Sam Altman, we’ve, ” Organizations: CNN Business, New York CNN, Google, Pfizer, Microsoft, Nvidia, Ark Investment Management, Apple, Wall Street, New York Times, Times, CNN, CNBC, Bravo, ” Locations: New York, Silicon Valley, Silicon

☆ A recession is imminent and favored tech stocks set to crater like the 'Nifty Fifty' did, BCA Research says
▼ + stars: | 2024-10-03 | by ( Samantha Subin | ) www.cnbc.com time to read: +2 min

The rise and fall of the "Nifty Fifty" stocks in the 1970s is a cautionary tale for investors in the Magnificent Seven craze, according to BCA Research. The "Nifty Fifty" refers to a loose group of stocks including Coca-Cola , IBM , Xerox and Pfizer , that rose to prominence in the 1970 to 1973 bull market. The comments from BCA come as the Magnificent Seven stocks continue powering the market to new heights despite a modest pullback this summer. The surge stems from ongoing bets around growth stocks and the artificial intelligence theme, especially as the Federal Reserve begins cutting rates. NVDA YTD mountain Nvidia in 2024 There are plenty of differences between the Nifty Fifty and the Magnificent Seven, Peta said, including megacap tech names' longer track record of outperforming the market.

Persons: Doug Peta, BCA's, Peta Organizations: BCA Research, IBM, Xerox, Pfizer, BCA, Federal Reserve, Nvidia

☆ It’s time to get flu and Covid-19 shots
▼ + stars: | 2024-10-02 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +7 min

Vaccines for Covid-19, flu and RSV are available now. Covid-19 vaccinesThe CDC recommends that everyone ages 6 months and older receive a Covid-19 vaccine this season to stay up to date. Flu vaccinesThe CDC also recommends a seasonal flu vaccine for everyone ages 6 months and older. Unlike the flu and Covid-19 vaccines, the RSV vaccine is one-time dose. The CDC says it’s also acceptable to get Covid-19, flu and RSV shots at one time, for those who are eligible.

Persons: Janet Hamilton, “ We’re, ” Hamilton, “, There’s, it’s, Dr, Sanjay Gupta Organizations: CNN, Respiratory, of State, Territorial, US Centers for Disease Control, CDC, Moderna, Pfizer, —, CNN Health Locations: United States

☆ Some steady names with income to ride out what's often a tumultuous October
▼ + stars: | 2024-10-01 | by ( Brian Evans | ) www.cnbc.com time to read: +2 min

The month is normally the most inconsistent for stocks going back to 1950, with an average S & P 500 daily move of 1.3% in either direction, per FactSet data. The S & P 500 and Nasdaq Composite are up more than 20% in 2024 through Monday's close, while the Dow Jones Industrial Average has popped 12%. The major averages also ended September with solid gains that brought the Dow and S & P 500 to record levels. Against this backdrop, CNBC Pro screened for stocks that can ride out any volatility in the month ahead, with a history of producing steady income. PFE YTD mountain Pfizer stock.

Persons: Stocks, Goldman Sachs, James Schneider Organizations: Nasdaq, Dow Jones, Dow, CNBC Pro, DirecTV, Pfizer, Drug Administration Locations: Monday's

☆ The one sector of the stock market that is cheap with upside today
▼ + stars: | 2024-09-29 | by ( Karen Firestone | ) www.cnbc.com time to read: +5 min

The table and chart below illustrate some characteristics of the biopharma stocks. The average price/earnings multiple for the group, using 2025 estimates, is 12.7 times versus 20.6 times for the S & P 500. A major knock on the biopharma group is the limited productivity from their extremely expensive research efforts, other than obesity drugs, over the past twenty-five years. The technology using AI might not be ready yet, particularly related to the complex biology of the human body. Complex programs exist already, such as AlphaFold, which predicts the structure of three-dimensional compounds using data on protein sequences.

Persons: Bristol Myers, Amgen, Eli Lilly, Lilly, Johnson Organizations: CNBC, Merck, Pfizer, Novo Nordisk, JPMorgan Locations: Bristol

Chin-Hong said the variant is a so-called recombinant of two other strains — KS.1.1 and KP.3.3 — meaning that genetic information was exchanged between them to form a third strain, XEC, Chin-Hong said. Is the XEC variant more contagious? Chan School of Public Health, said there’s no evidence yet that the XEC variant is much more transmissible than what’s currently circulating. The variant is closely related to KP.2, the strain targeted by the updated vaccines from Pfizer and Moderna. Bright, however, cautioned that clinical data is ultimately needed to determine how well the updated vaccines work against the XEC variant.

Persons: “, ”, Peter Chin, ” XEC, we’re, Rick Bright, Hong, Bill Hanage, ” Hanage, It’s, XEC, Hanage, “ It’s, Marc Johnson, Johnson, There’s, ” Chin, ” Johnson, ” Bright Organizations: Centers for Disease Control, Prevention, University of California, Biomedical, Research, Development Authority, Department of Health, Human Services, CDC, Harvard, of Public Health, University of Missouri School of Medicine, Pfizer, Moderna Locations: United States, San Francisco, Europe, Chin, U.S, Chan, Germany, Netherlands, France

☆ Timmons: The economic impact of a strike could be consequential
▼ + stars: | 2024-09-27 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailTimmons: The economic impact of a strike could be consequentialJay Timmons, President & CEO of the National Association of Manufacturers, warns that a strike could hurt manufacturers like Pfizer and Toyota by raising costs and disrupting supply chains.

Persons: Timmons, Jay Timmons Organizations: National Association of Manufacturers, Pfizer, Toyota

☆ Free Covid-19 tests are available again. Here’s how to get them
▼ + stars: | 2024-09-26 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +3 min

CNN —People in the United States can now order more free Covid-19 tests from the federal government as the country heads into respiratory virus season with high levels of the coronavirus already circulating. “Reopening this popular program is the latest step by the Biden-Harris Administration to ensure that over-the-counter COVID-19 tests are available to all who want them this fall and winter,” HHS Assistant Secretary for Preparedness and Response Dawn O’Connell said in a statement. More information about ordering these tests is available at ACL.gov/AccessibleTests. The CDC also recommends that everyone age 6 months or older receive an updated Covid-19 vaccine this season to stay up to date. The updated Covid-19 vaccines are available now at pharmacies across the US and can be received at the same time as the annual flu vaccine.

Persons: Harris, Dawn O’Connell, “, Dr, Sanjay Gupta, Mandy Cohen, CNN’s Brenda Goodman Organizations: CNN, People, US Postal Service, US Department of Health, Human Services, Biden, Harris Administration, Preparedness, Administration, Strategic Preparedness, US Centers for Disease Control, US Food and Drug Administration, CNN Health, CDC, Moderna, Pfizer Locations: United States, COVIDTests.gov, COVID, Covid

☆ Pfizer is a bottoming stock that will pay you to wait for the comeback, says Carter Worth
▼ + stars: | 2024-09-20 | by ( Carter Braxton Worth | ) www.cnbc.com time to read: +2 min

Former pharmaceutical champion Pfizer (PFE) , down 52% from its December 2021 all-time high, is judged to be in the throes of a "bearish-to-bullish" Reversal. Pfizer, the laggard the past year: Is now... Pfizer, the leader the past month: By our work, PFE represents a compelling "value play". And with a 5.73% dividend yield, one "gets paid" to wait as the stock continues to bottom. THIS CONTENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSITUTE FINANCIAL, INVESTMENT, TAX OR LEGAL ADVICE OR A RECOMMENDATION TO BUY ANY SECURITY OR OTHER FINANCIAL ASSET. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR.

Persons: Carter Braxton Worth Organizations: Pfizer, pharma, Pharmaceuticals Industry Group, CNBC, NBC UNIVERSAL

☆ Cramer's Lightning Round: 'Buy more' Pfizer
▼ + stars: | 2024-09-17 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Pfizer's year-to-date stock performance. Stock Chart Icon Stock chart icon First Solar's year-to-date stock performance. Stock Chart Icon Stock chart icon Equity Residential's year-to-date stock performance. Stock Chart Icon Stock chart icon Moderna's year-to-date stock performance. Stock Chart Icon Stock chart icon Vertiv's year-to-date stock performance.

Persons: Powell Organizations: Pfizer, Equity, Powell Industries

☆ GLP-1 pills are coming, and they could revolutionize weight-loss treatment
▼ + stars: | 2024-09-17 | by ( Meg Tirrell | ) edition.cnn.com time to read: +7 min

CNN —Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. At least a dozen similar experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing. Dushay cited hopes that pill versions of GLP-1 drugs could ease shortages, come at lower cost and enhance convenience. The oral GLP-1 raceRight on the heels of oral semaglutide is a group of drugs led by Eli Lilly’s orforglipron, an oral medication that also targets GLP-1, which is a hormone implicated in insulin regulation, appetite and digestion. Drugmakers including Pfizer and Roche, as well as smaller companies like Structure Therapeutics, Terns Pharmaceuticals and Viking Therapeutics, also have oral weight-loss drugs in earlier stages of development, BMO research shows.

Persons: Jared Holz, ” Holz, ”, Jody Dushay, Dushay, ” Dushay, it’s, Rybelsus, Jorge Moreno, “, ” Moreno, Eli Lilly’s orforglipron, Lilly, Evan Seigerman, amycretin, who’ve, Dr, Sanjay Gupta, Holz, he’s, he’d Organizations: CNN, Harvard Medical School, Beth Israel Deaconess Medical, Novo Nordisk, US Food and Drug Administration, Yale School of Medicine, BMO Capital Markets, Pfizer, Roche, Therapeutics, Terns Pharmaceuticals, Viking Therapeutics, BMO, Nordisk, European Association for, Diabetes, Inversago Pharma, CNN Health Locations: Danish, Novo

☆ Lightning Round: Buy more Pfizer, says Jim Cramer
▼ + stars: | 2024-09-17 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLightning Round: Buy more Pfizer, says Jim Cramer'Mad Money' host Jim Cramer weighs in on stock including: Pfizer, First Solar, Six Flags, Equity Residential, Vertiv, Moderna, and Powell Industries.

Persons: Jim Cramer Organizations: Pfizer, First, Equity, Moderna, Powell Industries Locations: Vertiv

☆ What to know about the available Covid-19, flu and RSV vaccines
▼ + stars: | 2024-09-16 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +8 min

But the Covid-19 vaccines provided 54% protection against symptomatic infection last season, CDC data shows, despite new variants that cropped up. The updated Covid-19 vaccines are available now, but ideal timing for getting the shot may differ based on individual circumstances. Unlike the flu and Covid-19 vaccines, the RSV vaccine is one-time dose. The CDC says it’s also acceptable to get Covid-19, flu and RSV shots at one time, for those who are eligible. Covid-19, flu and RSV vaccines are widely available at pharmacies across the US.

Persons: CNN —, There’s, Mandy Cohen, ”, ” Dr, Sandra Fryhofer, Fryhofer, Katelyn Jetelina, it’s, Dr, Sanjay Gupta Organizations: CNN, US Centers for Disease Control, CDC, Moderna, Pfizer, American Medical, —, CNN Health Locations: United States

☆ Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
▼ + stars: | 2024-09-14 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

Pfizer 's experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the drugmaker said Saturday. Patients with the condition, called cancer cachexia, who took Pfizer's treatment saw improvements in body weight, muscle mass, quality of life and physical function, according to the drugmaker. The condition affects about 9 million people worldwide, and 80% of cancer patients suffering from it are expected to die within one year of diagnosis, according to the company. Cancer cachexia is currently defined as a loss of 5% or more body weight over the past six months in cancer patients, along with symptoms such as fatigue, according to the National Cancer Institute. Allerton said a work group of experts defines a weight gain of greater than 5% as a "clinically meaningful difference in cancer patients with cachexia."

Persons: cachexia, Charlotte Allerton, Pfizer's, Allerton Organizations: Pfizer, National Cancer Institute, CNBC, European Society for Medical Oncology, The New England, of Medicine Locations: U.S, cachexia, Barcelona, Spain, The, Allerton

Ron DeSantis’ administration is once again advising against the mRNA vaccines: this time in the most vulnerable residents. In updated guidance for health care providers released Thursday, the Florida Health Department and state Surgeon General Joseph Ladapo questioned the safety and effectiveness of the mRNA Covid vaccines from Pfizer and Moderna, including for older adults and people with underlying health problems. Dr. Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia, said the Florida surgeon general's guidance is unnecessarily alarming people about the Covid vaccines. "The mRNA vaccines are remarkably safe," he added. The CDC currently recommends everyone ages 6 months and older get an updated Covid vaccine this fall from any of the three options.

Persons: Ron DeSantis ’, Joseph Ladapo, Nature Cardiovascular Research , Paul Offit, Offit, They’re, Isaac Bogoch, ”, Boguch, Ladapo Organizations: Florida Health Department, Pfizer, Moderna, Nature Cardiovascular Research, Children’s Hospital of Philadelphia, Food and Drug Administration, United States, University of Toronto, CDC, Emergency Locations: Florida, U.S

☆ Investors are ignoring 2 big risks to markets, says CIO, naming stocks that are bond 'substitutes'
▼ + stars: | 2024-09-13 | by ( Weizhen Tan | ) www.cnbc.com time to read: +3 min

Investors are ignoring two major risks to the market, according to Vahan Janjigian, chief investment officer at Greenwich Wealth Management. Geopolitical tensions and weak oil prices are the second risk, Janjigian said. He has been "surprised" that the Russia-Ukraine war, the Israel-Hamas conflict and weak oil prices haven't elicited a bigger reaction from the market. The International Energy Agency said in its recently monthly reports that global oil demand has been decelerating , adding that oil consumption in China — long the "engine of global oil demand growth" — contracted in April and May this year. In June, it added that Chinese oil demand contracted for a third consecutive month , driven by a slump in industrial activity.

Persons: Vahan Janjigian, CNBC's, Janjigian, —, Pfizer —, he's Organizations: Greenwich Wealth Management, U.S, International Energy Agency, IEA, IBM, Verizon, Pfizer, FactSet, Nvidia Locations: U.S, United States, U.S . Federal, Russia, Ukraine, Israel, China

The bank raised its price target on MercadoLibre Thursday to $2,500 from $2,225, suggesting 22% upside from Wednesday's close. The bank increased its price target to $230 from $200, implying nearly 16% upside from Wednesday's close. Supino also lifted the firm's price target to $93 a share, reflecting about 33% upside from Wednesday's close. Analyst Adam Berlin lowered his 12-month price target to $29 from $34, implying 6% downside. The investment firm's price target of $159 implies more than 2% downside from Wednesday's close.

Persons: Robert Ford Aguilar, — Michelle Fox, Wells, Wells Fargo, Eric Luebchow, Luebchow, Lisa Kailai Han, Sean Conlon, Wolfe, Peter Supino, Supino, Samantha Subin, BofA, George Staphos, a.m, Adam Berlin, Berlin, IPG, — Sean Conlon, Bernstein, Mark Moerdler, — Lisa Kailai Han, Stifel, Simon Yarmak, Andrea Pistacchi, Brandt Montour, it's, Montour, Fred Imbert Organizations: CNBC, Barclays, Bank of America, Diageo, Mercado, Mobile, Sprint, Wolfe Research, UBS downgrades, UBS, billings, GM, Pfizer, Oracle, Simon Property, Property Group, SPG, U.S, New York Stock Exchange Locations: Brazil, Mercado Pago, Wells Fargo, Wells, Roku, Berlin, America, U.S

☆ Stocks making the biggest moves midday: Kroger, Petco, Moderna, Roku and more
▼ + stars: | 2024-09-12 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

That builds on Wednesday's post-earnings rally of nearly 33%, which marked the stock's best day on record. Moderna — The stock plummeted nearly 16% after the drugmaker said it will cut $1.1 billion in expenses by 2027. Interpublic Group of Companies — The advertising stock was trading 2% lower following a downgrade from UBS to sell from neutral. U.S. Bancorp — The bank stock slipped nearly 2% despite announcing a dividend hike and a $5 billion share buyback plan. Oracle – Shares of the software company rose nearly 2% after Bernstein named it a top investment idea .

Persons: Kroger –, Kroger, Moderna, Adam Berlin, Bernstein, Yun Li, Michelle Fox, Sean Conlon, Samantha Subin, Lisa Kailai Han, Sarah Min Organizations: Kroger, Moderna, Gilead Sciences, Alaska Air Group, Interpublic, Companies, UBS, Amazon, Pfizer, Bancorp, Diageo, Bank of America, Wolfe Research, Oracle – Locations: Gilead, Alaska, U.S

☆ Check out these 11 U.S.-listed foreign stocks — which analysts give over 100% upside
▼ + stars: | 2024-09-11 | by ( Ganesh Rao | ) www.cnbc.com time to read: +3 min

The table below lists 11 stocks that analysts give over 100% upside potential in their local currency over the next 12 months. Investors should note that these stocks are exposed to foreign exchange fluctuations. Although the company has a primary listing on the Toronto stock exchange, the stock is also traded on U.S. stock exchanges . Valneva France-based Valneva has the second-biggest consensus upside potential on the list, at 213%. Stifel's price target of 9 euros ($9.94) a share indicates a 201% upside potential.

Persons: Desjardins, Frederic Tremblay, Canaccord, Katie Lachapelle, Meaghan, Valneva, Lyme, Christian Glennie, Evan Wang Organizations: CNBC Pro, Battery Metals, Valneva, Pfizer, Analysts, Guggenheim Securities Locations: U.S, Toronto, James Bay, Valneva France, Paris

☆ The Hard-Partying Lawyers Who Get Negligent Companies to Pay Billions
▼ + stars: | 2024-09-05 | by ( Jack Newsham | ) www.businessinsider.com time to read: +23 min

In 2023, mass-tort lawyers spent $152 million on TV ads and millions more on social media. The data provider X Ante estimated that in 2023, mass-tort lawyers spent $152 million on TV ads and millions more on social media. The decades that followed mass torts' onset on the national stage showed the big risks and big rewards of mass torts. AdvertisementIn a class action, a settlement is public, and the judge has to approve the lawyers' fees. But others are confident that indebted mass-tort lawyers can bounce back from a few bad bets.

Persons: Mike Papantonio, Pap, Johnson, Paul Cody, Bayer, Chris Seeger, audibles, Budd, Ness Motley, Motley Rice, South Carolina —, doling, Seeger, Wyeth, Phil Federico, Paul Hanly who'd, Federico, Lejeune, who've, Camp Lejeune, mack, Curt Miner, I've, Don Worley, Worley, —, Daniel A, Mark Lanier, wouldn't, Elizabeth Chamblee Burch, Burch, Ellen Relkin, Merck, Vioxx, There's, Lucian Pera, Keller Postman, Jeremy Troxel, Keller, Troxel, Michael McDonald, Warren Postman, Postman, Kelsey Vlamis, Jack Newsham Organizations: Wynn, Vegas, Camp Lejeune, pharma, Supreme, X, Pfizer, Defense, Marines, Veterans, Foreign, US Marine Corps, Johnson, University of Georgia, Business, Intuit, Rihanna, Morning Investments, Fortress Investment, Gramercy Funds, Deepwater, Investments Locations: Camp, Texas, South Carolina, Baltimore, North Carolina, Camp Lejeune, America, Beverly Hills , California, nonbanks

☆ This water treatment startup is already a unicorn, and has $225 million in VC funding
▼ + stars: | 2024-08-27 | by ( Diana Olick | In Dianaolick | ) www.cnbc.com time to read: +2 min

While it might seem like humans and animals consume most of the world's water, heavy industry uses up to half of it. That's why business sectors are looking for new ways to recycle water, especially in the face of increased drought. The global water and wastewater treatment market is expected to reach half a trillion dollars by the end of this decade, according to Statista. "Other technologies can recover maybe 50 to 60% of water, but we can recover 99% of water," Govindan said. It claims to save 1.7 billion gallons of water daily, or the amount consumed by 48 million people.

Persons: Prakash Govindan, Anurag Bajpayee, Govindan, Gradiant, Mark Danchak, Warburg Pincus, Lisa Rizzolo Organizations: Massachusetts Institute of Technology, MIT, BMW, Pfizer, Adnoc, General Innovation Capital Partners, G Investments, Clearvision Ventures, CNBC Locations: Statista, Veolia, Boston

☆ More free Covid tests will be available in late September, Biden admin says
▼ + stars: | 2024-08-23 | by ( Marlene Lenthang | Marlene Lenthang Is A Breaking News Reporter For Nbc News Digital. | ) www.nbcnews.com time to read: +1 min

Free Covid-19 tests will be available once again come late September, the Biden administration announced Friday. Under the program, four free Covid tests will be available by mail. “So as all of you prepare for travel and gatherings with family and the 2024 holiday season, don’t forget to go to Covidtests.gov to order your free tests,” she said. It comes as Covid rates have risen across most of the country over the summer, fueled by highly contagious new variants. Just Thursday, the Food and Drug Administration approved new Covid vaccines from Pfizer and Moderna, updated to better match the circulating strains of the virus.

Persons: Biden, Dawn O’Connell, O'Connell, ” Organizations: Department of Health, Human Services, Administration, Strategic Preparedness, Covid, Centers for Disease Control, Food and Drug Administration, Pfizer, Moderna Locations: Covidtests.gov

Search resuls for: "pfizer"

25 mentions found